KRAS and colorectal cancer: However, it has been shown that high PCSK9 protein levels are associated with shorter survival in colorectal cancer mice with Apc and Kras mutations (Villin-Cre; KrasG12D/+; ApcMin/+), but not mice with only the Apc mutation (wildtype Kras).